Skip to content

Clinical trials

Breast Neoplasms trials in Thailand

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Breast Neoplasms Country / region: Thailand Clear all

96 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20033
20065
20073
20083
20096
20105
20115
20127
20137
20146
20155
20163
20172
20183
20195
20203
20214
20223
20238
20242
20254
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed59
Active, not recruiting14
Recruiting10
Terminated7
Unknown status3
Approved for marketing2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoffmann-La Roche25
Novartis Pharmaceuticals19
AstraZeneca11
Meabco A/S5
Merck Sharp & Dohme LLC3
National Cancer Institute, Thailand3
Pfizer3
Genentech, Inc.2
GlaxoSmithKline2
Mahidol University2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Neoplasms96
Neoplasm Metastasis13
Neoplasms5
Triple Negative Breast Neoplasms3
Breast Diseases2
Multiple Endocrine Neoplasia Type 12
Neoplasms by Site2
Squamous Cell Carcinoma of Head and Neck2
Bone Diseases, Metabolic1
Brain Neoplasms1

Trials

Showing 76 to 96 of 96. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.